Abstract:Abstract STUDY QUESTION Does ovarian stimulation and the ovarian response affect embryo euploidy? SUMMARY ANSWER Ovarian stimulation and the ovarian response in women undergoing preimplantation genetic testing for monogenic disorders (PGT-M) cycles did not affect the rates of blastocyst euploidy. WHAT IS KNOWN ALREADY Whether or not ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET) has potential effects on embryo euploidy is controversial among studies for several reasons: (i) heterogeneity of the study populations, (ii) biopsies being performed at different stages of embryo development, and (iii) evolution of the platforms utilized for ploidy assessment. Patients who undergo PGT-M cycles typically have no additional risks of aneuploidy, providing an ideal study population for exploring this issue. STUDY DESIGN, SIZE, DURATION A retrospective cohort study including embryos undergoing preimplantation genetic testing for monogenic disorders (PGT-M) was conducted at a single academically affiliated fertility clinic between June 2014 and July 2021. PARTICIPANTS/MATERIALS, SETTING, METHODS A total of 617 women with 867 PGT-M cycles involving 12874 retrieved oocytes and 3106 trophectoderm biopsies of blastocysts were included. The primary outcome of the study was median euploidy rate, which was calculated by dividing the number of euploid blastocysts by the total number of biopsied blastocysts for each cycle. Secondary outcomes included the median normal fertilization rate (two-pronuclear (2PN) embryos/metaphase II (MⅡ) oocytes) and median blastulation rate (blastocyst numbers/2PN embryos). MAIN RESULTS AND THE ROLE OF CHANCE Comparable euploidy rates and fertilization rates were observed across all age groups, regardless of variations in ovarian stimulation protocols, gonadotropin dosages (both the starting and total dosages), stimulation durations, the inclusion of human menopausal gonadotrophin supplementation or the number of oocytes retrieved (all P > 0.05). Blastulation rates declined with increasing starting doses of gonadotropins in women aged 31–34 years old (P = 0.005) but increased with increasing gonadotrophin starting doses in women aged 35–37 years old (P = 0.017). In women aged 31–34, 35–37 and 38–40 years old, blastulation rates were significantly reduced with increases in the number of oocytes retrieved (P = 0.001, <0.001 and 0.012, respectively). LIMITATIONS, REASONS FOR CAUTION Limitations include the study's retrospective nature and the relatively small number of patients of advanced age, especially patients older than 40 years old, leading to quite low statistical power. Secondly, as we considered euploidy rates as outcome measures, we did not analyze the effects of ovarian stimulation on uniform aneuploidy and mosaicism respectively. Finally, we did not consider the effects of paternal characteristics on embryo euploidy status due to the fact that blastocyst aneuploidy primarily originates from maternal meiosis. However, sperm factors might have an effect on embryo development and the blastulation rate and therefore also number of blastocysts analyzed. The exclusion of patients with severe teratozoospermia and the fact that only ICSI was used as the insemination technique for women undergoing PGT-M contributed to minimize the effect of paternal factors. WIDER IMPLICATIONS OF THE FINDINGS Ovarian stimulation and response to stimulation did not affect blastocyst euploidy rates in women undergoing PGT-M cycles. However, in women aged 31-40 years old, there was a significant decline in blastulation rates as the number of retrieved oocytes increased. STUDY FUNDING/COMPETING INTEREST(S) This study was supported by the National Natural Science Foundation of China (Grant No. 81701407, 82301826); the National Key Research and Development Program of China (2022YFC2702901, 2022YFC2703004); China Postdoctoral Science Foundation (2022M710261) and China Postdoctoral Innovation Talent Support Program (BX20220020). There is no conflict of interest. TRIAL REGISTRATION NUMBER N/A

Does Smooth Endoplasmic Reticulum Aggregation in Oocytes Impact the Chromosome Aneuploidy of the Subsequent Embryos? A Propensity Score Matching Study

Oocytes With Smooth Endoplasmic Reticulum Aggregates May Not Impact Blastocyst Euploidy Rate

Blastocysts originated from oocytes with smooth endoplasmic reticulum aggregates have a reduced euploidy rate: a retrospective cohort study

Oocytes With Smooth Endoplasmic Reticulum Aggregates Are Not Associated With Impaired Reproductive Outcomes: A Matched Retrospective Cohort Study

Meta-analysis of the effects of smooth endoplasmic reticulum aggregation on birth outcome

Effect of oocytes with smooth endoplasmic reticulum aggregation on oocyte-to-embryo rate

Smooth Endoplasmic Reticulum Aggregates in Oocytes Associated with Increased Risk of Neonatal Birth Defects: A Meta-Analysis

Research progress on smooth endoplasmic reticulum aggregation in oocytes

Influence of Cleavage-Stage Embryo Quality on the In-Vitro Fertilization Outcome after Single Embryo Transfer in Fresh Cycles.

A higher incidence of cleavage failure in oocytes containing smooth endoplasmic reticulum clusters

Aneuploidy in Oocytes From Women of Advanced Maternal Age: Analysis of the Causal Meiotic Errors and Impact on Embryo Development

Effect of ovarian stimulation on embryo aneuploidy and mosaicism rate

Effects of Different Oocyte Cytoplasmic Granulation Patterns on Embryo Development and Euploidy: a Sibling Oocyte Control Study

Effects of ovarian stimulation on embryo euploidy: an analysis of 12 874 oocytes and 3106 blastocysts in cycles with preimplantation genetic testing for monogenic disorders

Effects of Ovarian Stimulation on Embryo Euploidy: an Analysis of 12874 Oocytes and 3106 Blastocysts in Cycles with Preimplantation Genetic Testing for Monogenic Disorders

Elevated sperm DNA fragmentation is correlated with an increased chromosomal aneuploidy rate of miscarried conceptus in women of advanced age undergoing fresh embryo transfer cycle

IVF Embryo Choices and Pregnancy Outcomes.

Differences in preimplantation blastocyst chromosomal aberrations between polycystic ovary syndrome women and controls: a multi-center retrospective cohort study

Permanence of de novo segmental aneuploidy in sequential embryo biopsies

Euploid Blastocyst Rates in Patients from POSEIDON Groups 3 and 4 Using Propensity Score Matching

Impact of recurrent pregnancy loss history on reproductive outcomes in women undergoing fertility treatment